The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 13, 2019
Filed:
Aug. 26, 2015
Applicants:
The Governing Council of the University of Toronto, Toronto, CA;
The University Court of the University of Aberdeen, Aberdeen, GB;
Inventors:
Ruth Ross, Toronto, CA;
Iain Greig, Aberdeen, GB;
Matteo Zanda, Aberdeen, GB;
Chih-Chung Tseng, Aberdeen, GB;
Assignees:
The University Court of the University of Aberdeen, Aberdeen, GB;
The Governing Council of the University of Toronto, Toronto, CA;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 209/10 (2006.01); C07D 209/12 (2006.01); C07D 401/04 (2006.01); C07D 405/06 (2006.01); C07D 409/06 (2006.01); C07D 209/14 (2006.01); A61P 25/14 (2006.01); A61P 25/34 (2006.01); A61P 27/02 (2006.01); A61P 17/06 (2006.01); A61P 27/06 (2006.01); A61P 9/10 (2006.01); A61P 19/00 (2006.01); A61P 25/28 (2006.01); A61P 25/30 (2006.01); A61P 43/00 (2006.01); A61P 1/16 (2006.01); A61P 9/00 (2006.01); A61P 11/06 (2006.01); A61P 25/22 (2006.01); A61P 25/32 (2006.01); A61P 19/02 (2006.01); A61P 9/12 (2006.01); A61P 13/12 (2006.01); A61P 25/18 (2006.01); A61P 25/24 (2006.01); A61P 1/00 (2006.01); A61P 19/08 (2006.01); A61P 25/00 (2006.01); A61P 25/08 (2006.01); A61P 25/16 (2006.01); A61P 29/00 (2006.01); A61P 1/08 (2006.01); A61P 19/10 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07D 209/14 (2013.01); A61P 1/00 (2018.01); A61P 1/08 (2018.01); A61P 1/16 (2018.01); A61P 9/00 (2018.01); A61P 9/10 (2018.01); A61P 9/12 (2018.01); A61P 11/06 (2018.01); A61P 13/12 (2018.01); A61P 17/06 (2018.01); A61P 19/00 (2018.01); A61P 19/02 (2018.01); A61P 19/08 (2018.01); A61P 19/10 (2018.01); A61P 25/00 (2018.01); A61P 25/08 (2018.01); A61P 25/14 (2018.01); A61P 25/16 (2018.01); A61P 25/18 (2018.01); A61P 25/22 (2018.01); A61P 25/24 (2018.01); A61P 25/28 (2018.01); A61P 25/30 (2018.01); A61P 25/32 (2018.01); A61P 25/34 (2018.01); A61P 27/02 (2018.01); A61P 27/06 (2018.01); A61P 29/00 (2018.01); A61P 35/00 (2018.01); A61P 43/00 (2018.01); C07D 209/10 (2013.01); C07D 209/12 (2013.01); C07D 401/04 (2013.01); C07D 405/06 (2013.01); C07D 409/06 (2013.01);
Abstract
The present disclosure relates to indole derivatives of the formula (I) which are cannabinoid type 1 receptor modulators and which are useful in the treatment of diseases in which modulation of the receptor is beneficial; to processes for their preparation; to pharmaceutical compositions comprising them; and to methods of using them.